Back to Homepage
  • News / Homepage
  • Dates and Deadlines
  • Welcome Letter
  • Organizers
  • Scientific Committees
  • Preliminary Programme
    • Detailed Programme
    • Satellite Symposia
  • Abstracts
  • Posters
  • Venue
  • Sponsors & Exhibitors
    • List of Sponsors
  • Registration
  • Accommodation
    • List of Hotels
      • Arbat Nord Hotel
      • Corinthia Hotel
      • Nevsky Hotel Grand
      • Radisson Sonya
  • Social Events
  • Tours
    • Sightseeings
    • Theatres
  • St. Petersburg
    • Get to the City
    • Transport in the City
    • Useful Tips
    • Photos
  • Russia
    • Russian Language
    • Russians
  • Contacts
  • Downloads & Links

Posters


Poster Area A


Acne and Related Disorders


P01 ADOLESCENT FACIAL ACNE VULGARIS AND BMI, ANY RELATIONSHIP
Ehiaghe L. Anaba (Nigeria), Adebola O. Ogunbiyi, Adekunle O. George

P02 EVALUATION OF RELATION BETWEEN ACNE DISEASE AND PSYCHIATRIC DISORDERS
Taheri R. (Iran), Behnam B., Ghorbani R.


Adverse Drug Reactions


P03 PSORIASIS INDUCED BY GROWTH HORMONE THERAPY: A CASE REPORT
Akar A., Açıkgöz G., Tunca M. (Turkey), Özmen İ., Arca E., Saifurrahman S.


Aging, Cosmetic Dermatology


P04 THE COMPARATIVE STUDY IN TREATMENT OF SOLAR LENTIGINES WITH TRICHLOROACETIC ACID 40% VS. CRYOTHERAPY
Goldust M. (Iran), Golforoushan F.

P05 EFFECT OF KOREAN RICE WINE CAKE ON SKIN AGING
Kang Y.J., Yoo J.M., Ji D.E., Park S.J., Song M.C., Kim T.J. (South Korea)

P06 CARBOXYTHERAPY – NON-INVASIVE METHOD IN DERMATOLOGY
Zelenkova H. (Slovak Republic), Stracenska J.


Atopic Dermatitis


P07 THE LEVEL OF THE INSULIN, PROINSULIN AND ANTIBODIES TO INSULIN ANTIGEN IN PATIENTS WITH ATOPIC DERMATIS
Rudych N. (Russia)

P08 YS2242 SUPPRESSES IG E-MEDIATED ALLERGIC RESPONSE BY THE INHIBITION OF CERAMIDE KINASE IN MAST CELL
Yoo J.M., Kang Y.J., Song M.C., Jung M.H., Kim Y.J., Park S.J., Ji D.E., Kim T.J. (South Korea)


Dermatopathology


P09 INNATE IMMUNITY IN THE LESIONAL PSORIATIC SKIN DURING INFLIXIMAB TREATMENT
Katunina O.R. (Russia)

P10 SYRINGOCYSTADENOMA PAPILLIFERUM ASSOCIATED WITH AN SEBACEUS NEVUS
Sarac F. (Romania), Fratila S.


Epidemiology


P11 EPIDEMIOLOGICAL PARTICULARITIES OF SKIN CANCER IN UNIVERSITY REFERENCE CENTERS FROM ROMANIA
Turcu G. (Romania), Popescu I., Carstea E.M., Forsea D., Giurcaneanu C., Forsea A.M.


Immunology, Bullous Diseases


P12 VEGF FROM KERATINOCYTES INHIBITS DENDRITIC CELL ACTIVATION AND MIGRATION IN ARSENIC MILIEU
Hong C.-H., Lee C.-H. (Taiwan), Yu H.-S.


Infections


P13 PITYRIASIS LICHENOIDES CHRONICA: CASES REPORTS
Chiriac A. (Romania), Suditu G., Mihaila D., Chirana A.

P14 ATYPICAL MYCOBACTERIAL INFECTION MIMICKING FACIAL ACNE
Kwok C. (Singapore), Tan K.W.

P15 ERYTHEMA INDURATUM OF BAZIN – THE IMPORTANCE OF AN ACCURATE DIAGNOSIS
Maio P. (Portugal), Vieira R., Assis Pacheco F., Jorge C., Jorge C.

P16 DISSEMINATED HERPES ZOSTER IN A PATIENT WITH CROHN’S DISEASE
Tunca M. (Turkey), Yeşil H., Açıkgöz G., Akar A.


Internal Medicine – Including Connective Tissue Diseases


P17 TERBINAFINE-INDUCED SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS
Conde Fernandes I., Lobo I., Selores M. (Portugal)


Invasive & Non Invasive Techniques as Diagnostic Tools, Dermatoscopy


P18 OPTICAL BIOPSY OF SKIN LESIONS – NONINVASIVE METHOD FOR DIAGNOSTIC ASSESSMENT
Pavlova E. (Bulgaria), Troyanova P., Borisova E., Avramov L.

Lymphomas and Histiocytoses


P19 PRIMARY CUTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA, OTHER TYPE
Chua S. (Philippines), Naagas V., Angeles C., Lat-Herrin K.


Melanoma and Non-Melanoma Skin Cancers


P20 MELANOMA IN A REAL LIFE SETTING. DATA FROM A PRIVATE OFFICE IN BRAZIL
Castro L. (Brazil), Donati A., Delgado L.

P21 MOLECULAR MECHANISMS OF SPHINGOLIPID-INDUCED APOPTOSIS IN MELANOMA CELLS IN VIVO & IN VITRO
Martinova E.A. (Russia)


Miscellaneous


P22 DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS IN A TYPE III/IV SKIN TYPE
Ramaswamy P., Konnikov N. (USA)

P23 FAMILIAL MULTIPLE LIPOMATOSIS: A CASE REPORT
Rosmaninho A., Vilaça S., Machado S. (Portugal), Selores M.


Molecular Biology and Skin Biology


P24 METAL ACTIVATION OF TYROSINASE AS THE KEY ENZYME OF MELANOGENESIS PATHWAY
Gheibi N. (Iran), Saboury A.A., Sarreshtehdari M.

P25 ARSENIC ENHANCES LANGERHANS CELL MIGRATION TO DRAINING LYMPH NODES VIA CCL21 AND IFN-γ PRODUCTION
Yu H.-S. (Taiwan), Hong C.-H., Lee C.-H., Wang L.-F.

P26 THE ROLE OF SPHINGOLIPIDS IN SKIN AGING
Kandalova A., Kandalova O. (Russia), Perlamutrov U.

P27 DISULFIDE CROSS-LINKING PROCEEDS AFTER THE ASSEMBLY OF LORICRIN BY TRANSGLUTAMINASE 1
Yamanishi K. (Japan), Yamamoto M., Nakagawa N., Sakaguchi Y., Mizuno Y., Suga Y.


Occupational Dermatoses


P28 SENSITIVITY TO KATHON CG ®: FINDINGS IN 629 CONSECUTIVE PATIENTS
Maio P. (Portugal), Carvaçlho R.R., Amaro C., Santos R.



Poster Area B


Pediatric Dermatology


P29 AQUIRED CUTIX LAXA IN A 6 YEAR OLD GIRL: A CASE REPORT
Ehiaghe L. Anaba (Nigeria), Adebola O. Ogunbiyi, Adekunle O. George

P30 BART'S SYNDROME
Machado S. (Portugal), Rosmaninho A., Selores M.

P31 VON ZUMBUSCH PSORIASIS AND ALBRIGHT SYNDROME IN A CHILD
Maio P. (Portugal), Fernandes S., Fitas A. , Conde M., Sasseti L., Abranches M., Freitas I., Cardoso J.


Pharmacology and Drug Therapy


P32 PHOTOACOUSTIC TECHNIQUE TO PERCUTANEOUS PERMEATION OF TOPICAL PHTHALOCYANINES
Beltrame Jr. M. (Brazil), Silva E.P.O., Cardoso L.E., Barja P.R.

P33 NECROBIOSIS LIPOIDICA TREATED WITH INTRALESIONAL CORTICOSTEROIDS AND TOPICAL IMMUNOMODULATORY AGENT
Brajac I. (Croatia), Kaštelan M., Peternel S., Puizina Ivić N.

P34 A NEUTROPENIC CHILD PATIENT WITH ACUTE GRAFT-VERSUS-HOST DISEASE TREATED WITH IVIG
Dinçer D., Tunca M. (Turkey), Akar A., Ataş E.


Phlebology, Lymphology


P35 LIPODERMATOSCLEROSIS: THE TREATMENT OUTCOME WITH HYDROXYCHLOROQUINE AND PENTOXIFYLLINE
Choonhakarn C. (Thailand), Chaowattanapanit S.


Psoriasis and Related Disorders


P36 A NEW APPROACH IN TREATMENT OF PSORIASIS
Al-Gammal AGh. (Egypt)

P37 SUSTAINED EFFICACY OF USTEKINUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN INITIAL RESPONDERS CONTINUING WITH MAINTENANCE THERAPY THROUGH YEAR 3
Gordon K., Lambert J., Gratton D., Baker D., Matheson R., Yeilding N., Fakharzadeh S., Li S., Guenther L.

P38 USTEKINUMAB SAFETY UPDATE: CUMULATIVE EXPERIENCE FROM LONGER TERM FOLLOW-UP OF PATIENTS TREATED IN THE USTEKINUMAB PSORIASIS CLINICAL DEVELOPMENT PROGRAM
Gordon K., Leonardi C., Griffiths C.E.M., Szapary P.O., Reich K.

P39 MENTAL STATUS STUDY IN PSORIASIS PATIENTS
Kandalova A., Zodionchenko E., Perlamutrov U. (Russia)

P40 MECHANISMS OF THE SPHINGOLIPID-DEPENDENT CELL PROLIFERATION UNDER PSORIASIS
Kandalova O. (Russia)

P41 SAFETY OF PATIENTS WITH LATENT TUBERCULOSIS TREATED WITH USTEKINUMAB ACROSS 5 PHASE 3 CLINICAL TRIALS IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS
Tsai T.F. (Taiwan), Ho V., Song M., Szapary P., Kato T., Wasfi Y., Li S., Shen Y.K.

P42 THE THERAPEUTIC EFFICIENCY OF INFLIXIMAB IN PSORIASIS ON THE BASIS OF MOLECULAR RESEARCHES
Znamenskaja L.F. (Russia), Frigo N.V., Zilova M.B., Yakovleva S.V., Rotaniv S.V.


Psychodermatology


P43 FUNCTIONAL ITCH
Bobko S. (Russia), Lvov A.


STDs & AIDS


P44 NATIONAL TRENDS IN HIV INFECTION AMONG WOMEN IN THE UKRAINE
Burruano L. (Germany)

P45 NEISSERIA GONORRHOEAE INFECTIONS AT STD CLINICS IN HOSPITAL CURRY CABRAL – A 2-YEAR STUDY
Maio P. (Portugal), Carvalho R., Santos R., Fernandes C., Rodrigues A., Cardoso J.

P46 A STUDY ON THE USE OF IMIQUIMOD FOR THE TREATMENT OF GENITAL MOLLUSCUM CONTAGIOSUM AND GENITAL WARTS IN FEMALE PATIENTS
Puri N. (India)


Urticaria and Mast Cell Disorders


P47 MASTOCYTOSIS AS SCARRING ALOPECIC PLAQUE
Fratila S. (Romania), Sarac F., Puscasiu M.


Wound Healing


P48 EFFECT OF THE LOW LEVEL LASER AND PHOTOSENSITIZER DYE IN CUTANEOUS WOUND HEALING
Tedesco A.C. (Brazil), Simioni A.R., Couty L., Coulomb B.


Various Topics


P49 METHOD OF TREATMENT AS A FACTOR AFFECTING THE RECURRENCE RATE OF BASAL CELL CARCINOMA
Troyanova P. (Bulgaria), Pavlova E.




Copyright © GUARANT International
All rights reserved
Visitors:10250
Developed by: BUSINESS PARTNERS FOR YOU s.r.o.